دورية أكاديمية
أعرض في EDS

COVID-19 in Pediatric Populations.

التفاصيل البيبلوغرافية
العنوان: COVID-19 in Pediatric Populations.
المؤلفون: Okuducu YK; Department of Pediatrics, Pulmonary Division, Massachusetts General Hospital, 175 Cambridge Street, 5(th) floor, Boston, MA 02114, USA; Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Mall MA; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin Augustenburger Platz 1, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 13353, Germany; German Center for Lung Research (DZL), Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany., Yonker LM; Department of Pediatrics, Pulmonary Division, Massachusetts General Hospital, 175 Cambridge Street, 5(th) floor, Boston, MA 02114, USA; Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: lyonker@mgh.harvard.edu.
المصدر: Clinics in chest medicine [Clin Chest Med] 2024 Sep; Vol. 45 (3), pp. 675-684.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Health Sciences Division Country of Publication: United States NLM ID: 7907612 Publication Model: Print Cited Medium: Internet ISSN: 1557-8216 (Electronic) Linking ISSN: 02725231 NLM ISO Abbreviation: Clin Chest Med Subsets: MEDLINE
أسماء مطبوعة: Publication: <2005->: Philadelphia : Elsevier Health Sciences Division
Original Publication: Philadelphia, Saunders.
مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/complications , SARS-CoV-2*, Humans ; Child ; Systemic Inflammatory Response Syndrome/epidemiology ; Systemic Inflammatory Response Syndrome/therapy ; Child, Preschool ; Risk Factors ; Age Factors
مستخلص: The COVID-19 pandemic reshaped the landscape of respiratory viral illnesses, causing common viruses to fade as SARS-CoV-2 took precedence. By 2023, more than 96% of the children in the United States were estimated to have been infected with SARS-CoV-2, with certain genetic predispositions and underlying health conditions posing risk factors for severe disease in children. Children, in general though, exhibit immunity advantages, protecting against aspects of the SARS-CoV-2 infection known to drive increased severity in older adults. Post-COVID-19 complications such as multisystem inflammatory syndrome in children and long COVID have emerged, underscoring the importance of vaccination. Here, we highlight the risks of severe pediatric COVID-19, age-specific immunoprotection, comparisons of SARS-CoV-2 with other respiratory viruses, and factors contributing to post-COVID-19 complications in children.
Competing Interests: Disclosure The authors have nothing to declare.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
فهرسة مساهمة: Keywords: COVID-19; Long COVID; Multisystem inflammatory in children; Pediatric
SCR Disease Name: pediatric multisystem inflammatory disease, COVID-19 related
تواريخ الأحداث: Date Created: 20240728 Date Completed: 20240728 Latest Revision: 20240728
رمز التحديث: 20240729
DOI: 10.1016/j.ccm.2024.02.019
PMID: 39069330
قاعدة البيانات: MEDLINE
الوصف
تدمد:1557-8216
DOI:10.1016/j.ccm.2024.02.019